Latest Trading Suspension News

Equity Story Group Ltd has voluntarily suspended trading of its shares pending a forthcoming announcement about a capital raise, signaling a significant funding event.

Theta Gold Mines has requested a voluntary suspension of its shares on the ASX pending a significant announcement related to funding and its TGME Gold Mine Project.

European Lithium Limited will lift its trading suspension on 3 October 2025 following the release of its Annual Financial Report, marking a key milestone for investors.

The Federal Court has approved QGold’s compulsory acquisition of Carawine Resources’ remaining shares at 11 cents each, setting the stage for Carawine’s imminent ASX suspension and delisting.

Gold Mountain Limited has had its trading suspension lifted immediately following the release of details on a recent capital raising placement.

Gold Mountain Limited has increased its capital raise to $2 million by issuing nearly 30 million shares at a slightly higher price, lifting its voluntary trading suspension and reinforcing its exploration ambitions.

Aurum Resources Limited has had its trading suspension lifted immediately following the lodgement of its annual financial report, allowing its shares to resume trading on the ASX.

Orion Minerals Ltd has been reinstated to ASX quotation following the release of its 2025 annual report and a new capital raising announcement, ending its trading suspension.

BPH Global Ltd will lift its trading suspension on 2 October 2025 following the lodgement of its annual financial report for the year ended 30 June 2025.

DGR Global Limited will have its trading suspension lifted on 2 October 2025 following the lodgement of its annual report, marking a key step back to market normalcy.

Australian Pacific Coal Limited has delayed its full year accounts due to missing financial data from its Dartbrook mine subsidiary, leading to a trading suspension from October 1.

Invex Therapeutics Ltd has had its trading suspension lifted following the announcement of a material acquisition, signaling a pivotal moment for the biotech company.